Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1957 Jul;36(7):1072–1080. doi: 10.1172/JCI103502

Acute Respiratory Illness in Volunteers Following Intramuscular Administration of Live Adenovirus

M R Hilleman a, R E Hodges a,1, M S Warfield a, S A Anderson a
PMCID: PMC1072693  PMID: 13449159

Full text

PDF
1076

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON S. A., HILLEMAN M. R., WARFIELD M. S., WERNER J. H. Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development. J Am Med Assoc. 1957 Jan 5;163(1):4–15. doi: 10.1001/jama.1957.02970360006002. [DOI] [PubMed] [Google Scholar]
  2. BELL J. A., ROWE W. P., ENGLER J. I., PARROTT R. H., HUEBNER R. J. Pharyngoconjunctival fever; epidemiological studies of a recently recognized disease entity. J Am Med Assoc. 1955 Mar 26;157(13):1083–1092. doi: 10.1001/jama.1955.02950300011003. [DOI] [PubMed] [Google Scholar]
  3. CHAPRONIERE D. M., PEREIRA H. G., RODEN A. T. Infection of volunteers by a virus (A.P.C. type 1) isolated from human adenoid tissue. Lancet. 1956 Sep 22;271(6943):592–596. doi: 10.1016/s0140-6736(56)92291-7. [DOI] [PubMed] [Google Scholar]
  4. DASCOMB H. E., HILLEMAN M. R. Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). Am J Med. 1956 Aug;21(2):161–174. doi: 10.1016/0002-9343(56)90049-3. [DOI] [PubMed] [Google Scholar]
  5. ENDERS J. F., BELL J. A., DINGLE J. H., FRANCIS T., Jr, HILLEMAN M. R., HUEBNER R. J., PAYNE A. M. Adenoviruses: group name proposed for new respiratory-tract viruses. Science. 1956 Jul 20;124(3212):119–120. doi: 10.1126/science.124.3212.119. [DOI] [PubMed] [Google Scholar]
  6. GINSBERG H. S., BADGER G. F., DINGLE J. H., JORDAN W. S., Jr, KATZ S. Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD). J Clin Invest. 1955 Jun;34(6):820–831. doi: 10.1172/JCI103137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HILLEMAN M. R., STALLONES R. A., GAULD R. L., WARFIELD M. S., ANDERSON S. A. Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine. Proc Soc Exp Biol Med. 1956 Jun;92(2):377–383. doi: 10.3181/00379727-92-22484. [DOI] [PubMed] [Google Scholar]
  8. HILLEMAN M. R., TOUSIMIS A. J., WERNER J. H. Biophysical characterization of the RI (RI-67) viruses. Proc Soc Exp Biol Med. 1955 Aug;89(4):587–593. doi: 10.3181/00379727-89-21884. [DOI] [PubMed] [Google Scholar]
  9. HILLEMAN M. R., WERNER J. H., DASCOMB H. E., BUTLER R. L. Epidemiologic investigations with respiratory disease virus RI-67. Am J Public Health Nations Health. 1955 Feb;45(2):203–210. doi: 10.2105/ajph.45.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HILLEMAN M. R., WERNER J. H., DASCOMB H. E., BUTLER R. L., STEWART M. T. Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. Am J Hyg. 1955 Jul;62(1):29–42. doi: 10.1093/oxfordjournals.aje.a119764. [DOI] [PubMed] [Google Scholar]
  11. HILLEMAN M. R., WERNER J. H. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954 Jan;85(1):183–188. doi: 10.3181/00379727-85-20825. [DOI] [PubMed] [Google Scholar]
  12. HILLEMAN M. R., WERNER J. H., STEWART M. T. Grouping and occurrence of RI (prototype RI-67) viruses. Proc Soc Exp Biol Med. 1955 Dec;90(3):555–562. doi: 10.3181/00379727-90-22097. [DOI] [PubMed] [Google Scholar]
  13. HUEBNER R. J., ROWE W. P., SCHATTEN W. E., SMITH R. R., THOMAS L. B. Studies on the use of viruses in the treatment of carcinoma of the cervix. Cancer. 1956 Nov-Dec;9(6):1211–1218. doi: 10.1002/1097-0142(195611/12)9:6<1211::aid-cncr2820090624>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  14. HUEBNER R. J., ROWE W. P., WARD T. G., PARROTT R. H., BELL J. A. Adenoidal-pharyngeal-conjunctival agents: a newly recognized group of common viruses of the respiratory system. N Engl J Med. 1954 Dec 30;251(27):1077–1086. doi: 10.1056/NEJM195412302512701. [DOI] [PubMed] [Google Scholar]
  15. HULL R. N., MINNER J. R., SMITH J. W. New viral agents recovered from tissue cultures of monkey kidney cells. I. Origin and properties of cytopathogenic agents S.V.1, S.V.2, S.V.4, S.V.5, S.V.6, S.V.11, S.V.12 and S.V.15. Am J Hyg. 1956 Mar;63(2):204–215. doi: 10.1093/oxfordjournals.aje.a119804. [DOI] [PubMed] [Google Scholar]
  16. RUSTIGIAN R., JOHNSTON P., REIHART H. Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med. 1955 Jan;88(1):8–16. doi: 10.3181/00379727-88-21478. [DOI] [PubMed] [Google Scholar]
  17. SOUTHAM C. M., HILLEMAN M. R., WERNER J. H. Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. J Lab Clin Med. 1956 Apr;47(4):573–582. [PubMed] [Google Scholar]
  18. WARD T. G., HUEBNER R. J., ROWE W. P., RYAN R. W., BELL J. A. Production of pharyngoconjunctival fever in human volunteers inoculated with APC viruses. Science. 1955 Dec 2;122(3179):1086–1087. doi: 10.1126/science.122.3179.1086. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES